Recro Pharma, Inc. 4
4 · Recro Pharma, Inc. · Filed Mar 13, 2014
Insider Transaction Report
Form 4
Garner Charles
CFO and Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2014-03-12+81,026→ 81,026 totalExercise: $8.00Exp: 2024-03-12→ Common Stock (81,026 underlying)
Footnotes (1)
- [F1]The option vests monthly in equal proportions over a period of four years beginning on March 12, 2014 and on the 12th of each month thereafter.